medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2011; 10 (1)


Protective and curative effects of polyphenolic extracts from Ichnocarpus frutescense leaves on experimental hepatotoxicity by carbon tretrachloride and tamoxifen

Kumarappan C, Vijayakumar M, Thilagam E, Balamurugan M, Thiagarajan M, Senthil S, Das SC, Mandal SC

Idioma: Español
Referencias bibliográficas: 44
Paginas: 63-72
Archivo PDF: 311.46 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Meyer SA, Kulkarni AP. Introduction to biochemical toxicology, Hepatotoxicity. In: Hodgson E, Smart RC (eds.). 3rd. Ed. A. New York: John Wiley & Sons Inc; 2001, p. 487-90.

  2. Tomboloni A, Cingolani M. Fatal accidental ingestion of carbon tetrachloride: a postmortem distribution study. J Forensic Sci 1996; 41(1): 166-8.

  3. Tesehke CB, Vierke W, Goldermann L. Carbon tetrachloride levels and serum activities of liver enzymes following acute carbon tetrachloride intoxication. Toxicol Lett 1983; 17(1-2): 175-80.

  4. Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Natl Rev Drug Discov 2003; 2: 205-13.

  5. Williams GM, Iatropoulos MJ, Djordjevic MV, Kaltenberg OP. The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis 1993; 14: 315-17.

  6. Dehal SS, Kupfer D. CYP2D6 catalyzes tamoxifen 4- hydroxylation in human liver. Cancer Res 1997; 57: 3402-6.

  7. Fowler JS. Carbon tetrachloride metabolism in the rabbit. Br J Pharmacol 1969; 37: 733-7.

  8. Emile FN, Dragan YP, Colin RJ, Jordan VC, Pitot, HC. Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver. Cancer Res 1995; 55: 1780-6.

  9. Wong FW, Chan WY, Lee SS. Resistance to carbon tetrachloride induced hepatotoxicity in mice which lack CYP 2E1 expression. Toxicol App Pharmacol 1998; 153: 109-18.

  10. Boll M, Weber LW, Becker E, Stampfl A. Mechanism of Carbon Tetrachloride-Induced Hepatotoxicity. Hepatocellular Damage by Reactive Carbon Tetrachloride Metabolites. Z Naturforsch 2001; 56: 649-59.

  11. Mitra SK, Venkataranganna MV, Sundaram R, Gopumadhavan S. Protective effect of HD-03, a herbal formulation, against various hepatotoxic agents in rats. J Ethnopharmacol 1998; 63(3): 181-6.

  12. Sies H. Strategies of antioxidant defence. Europ J Biochem 1993; 215(2): 213-19.

  13. Letteron P, Labbe G, Degott C, Berson A, Fromenty B, Delaforge M, Larrey D, Pessayre D. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol 1990; 39: 2027-34.

  14. Rosen GM, Britigan BE, Halpern HJ, Pou S. Spin trapping free radicals in biological systems; in Free Radicals, Biology and Detection by Spin Trapping. Oxford Press New York: Oxford; 1999, p. 394.

  15. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv Pharmacol 1997; 38: 601-28.

  16. Bass NM. Is there any use for nontraditional or alternative therapies in patients with chronic liver disease? Curr Gastro Rep 1999; 1(1): 50-6.

  17. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Ann Rev Nutr 2002; 22: 19-34.

  18. Breinholt V, Lauridsen ST, Dragsted LO. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica 1999; 29(12): 1227-40.

  19. Hikino H, Kiso Y. Natural products for liver diseases. In: Economical and medicinal plant research. Vol. 2. London: Academic Press; 1988, p. 39-72.

  20. Anonymous. Wealth of India. Raw Materials, Council of Scientific and Industrial Research (CSIR). Vol. V. New Delhi: CSIR; 1976, p. 162-3.

  21. Lakshmi DKM, Venkata Rao E, Venkata Rao D. Triterpenoid constituents of Ichnocarpus frutescens. Indian Drugs 1985; 22: 552-3.

  22. Singh RP, Singh RP. Flavonoids of the flowers of Ichnocarpus frutescens. J Indian Chem Soc 1987; 14: 715-56.

  23. Parinitha M, Harish GU, Vivek NC, Mahesh T, Shivanna MB. Ethno-botanical wealth of Bhadra wild life sanctuary in Karnataka. Indian J Trad Knowl 2004; 3(1): 37-50.

  24. Bhandary MJ, Chandrashekar KR, Kaveriappa KM. Medical Ethnobotany of the Siddis of Uttara Kannada District, Karnataka, India. J Ethnopharm 1995; 47(3): 149-58.

  25. Kang SY, Sung SH, Park JH, Kim YC. Hepatoprotective activity of scopoletin, a constituent of Solanum lyratum. Arch Pharm Res 1998; 21(6): 718-22.

  26. Kumarappan, CT, Chandra R, Mandal SC. Anti-inflammatory activity of Ichnocarpus frutescens. Pharmacologyonline 2006; 3: 201-16.

  27. Kumarappan, CT, Mandal SC. Antitumor activity of polyphenolic extract of Ichnocarpus frutescens. Exp Oncol 2007; 29(2): 94-101.

  28. Kumarappan, CT, Mandal SC. Polyphenolic extract of Ichnocarpus frutescens attenuates diabetic complications in streptozotocin treated diabetic rats. Renal Failure 2008; 30(3): 307-22.

  29. Mukherjee S, Sur A, Maiti BR. Hepatoprotective effect of Swertia chirata on rat. Ind J Exp Biol 1997; 35(4): 384-8.

  30. El-Beshbishy H. The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen induced liver injury in rats: DDB use is curative or protective. J Biochem Mol Biol 2005; 38(3): 70-7.

  31. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82(1): 70-7.

  32. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95(2): 351-8.

  33. Brauer RW, Root MA. The effect of carbon tetrachloride induced liver injury upon the acetylcholine hydrolyzing activity of blood plasma of the rat. J Pharmacol Exp Ther 1946; 88(2): 109 - 118.

  34. Vogel G. New natural products and plants with drugs, pharmacological, biological or therapeutical activity. H. Wagner and P. Wolff (eds.). Heidelberg, Berlin: Springer Verlag: 1977, p. 240-65.

  35. Mazel P. Experiments illustrating drug metabolism in vitro. In: La Du, BN, Mandel HG, Way EL (eds.). Fundamentals of drug metabolism and drug disposition. Baltimore: Williams and Wilkins; 1971, p. 546-50.

  36. Agarwal AK, Mehendale HM. Chlordecone potentiation of carbon tetrachloride hepatotoxicity in ovariectomized rats. Toxicol 1984; 29(4): 315-23.

  37. Pencil SD, Brattin WJ, Glende EA, Recknagel RI. Carbon tetra chloride dependent inhibition of lipid secretion by isolated hepatocytes characterization and requirement for bioactivation. Biochem Pharmacol 1984; 33(15): 2419-23.

  38. Recknagel RO, Glonde EA, Dolak JA, Walter RL. Mechanism of carbon tetrachloride toxicity. Pharmacol Therap 1989; 43(1): 139-54.

  39. Farber JL, Gerson RJ. Mechanisms of cell injury with hepatotoxic chemicals. Pharmacol Rev 1984; 36(2): 71S-75S.

  40. Azri S, Mata HP, Reid LL, Gandolfi AJ, Brendel K. Further examination of the selective toxicity of CCl4 in rat liver slices. Toxicol Appl Pharmacol 1992; 112(1): 81-6.

  41. Desai P, Nallani S, Sane R, Moore L, Goodwin B, Buckley D, Buckley A. Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4- Hydroxytamoxifen. Drug Metab Disp 2002; 30(5): 608-12.

  42. Athoupa M, Hirsimaki P, Parssinen R, Mantyla E. Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen induced hepatocarcinogenesis in rats. Carcinogenesis 1994; 15(5): 863-8.

  43. Aguiar M, Masse R, Gibbs BF. Regulation of cytochrome P450 by posttranslational modification. Drug Metab Rev 2005; 37: 379-404.

  44. Cooper DY. Discovery of the function of the heme protein P-450: a systematic approach to scientific research. Life Sci 1973; 13: 1151-61.




2020     |     www.medigraphic.com